Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder

The Use of a Series of Ketamine Infusions in Two Patients With Treatment-Resistant Depression

(2014) Michael Messer et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

A Case of Sustained Remission Following an Acute Course of Ketamine in Treatment-Resistant Depression

(2011) James W. Murrough et al.   JOURNAL OF CLINICAL PSYCHIATRY

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

(2011) Lobna Ibrahim et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era

(2010) Noah S Philip et al.   EXPERT OPINION ON PHARMACOTHERAPY

The Future of Psychopharmacology of Depression

(2010) Trina Chang et al.   JOURNAL OF CLINICAL PSYCHIATRY

The role of glutamate on the action of antidepressants

(2010) Kenji Hashimoto   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Glutamatergic Modulators: The Future of Treating Mood Disorders?

(2010) Carlos Zarate et al.   HARVARD REVIEW OF PSYCHIATRY

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Emerging role of glutamate in the pathophysiology of major depressive disorder

(2009) Kenji Hashimoto   BRAIN RESEARCH REVIEWS

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

(2009) Sanjay J. Mathew et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases

(2008) Robert Paul et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY